Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Unapproved Depression Drug Remains Available In US In Supplements To Treat Opioid Addiction

Aug 25 2020

• By Malcolm Spicer

Time for action

Related Content

DEA Proposal To Schedule Kratom Stirs Wave Of Opposition

Dec 08 2016

Opioid Treatment Claims Linked To Depression Drug Found In Supplements

Nov 21 2018

Opioid Abuse Treatment Claims Prompt FDA Warnings To Two Kratom Marketers

Jun 25 2019

Additional Topics

International United States US States FDA Enforcement Dietary Supplements Advertising, Marketing & Sales Commercial Compliance Distribution Ingredients Manufacturing Policy Regulation Safety Consumer

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window